These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37103072)

  • 1. Expression of ALCAM in Clinical Colon Cancer and Relationship With Patients' Treatment Responses.
    Fang Z; Zeng JJ; Yang Y; Ruge F; Lane J; Hargest R; Jiang WG
    In Vivo; 2023; 37(3):1117-1128. PubMed ID: 37103072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential 'Seed' and 'Soil' Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers.
    Yang YM; Ye L; Ruge F; Fang Z; Ji K; Sanders AJ; Jia S; Hao C; Dou QP; Ji J; Jiang WG
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient's Response to Chemotherapies.
    Yang YM; Ruge F; Ji KE; Jia S; Jia Y; Sanders AJ; Ji J; Jiang WG
    Anticancer Res; 2023 Apr; 43(4):1463-1475. PubMed ID: 36974802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator.
    King JA; Ofori-Acquah SF; Stevens T; Al-Mehdi AB; Fodstad O; Jiang WG
    Breast Cancer Res; 2004; 6(5):R478-87. PubMed ID: 15318930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
    Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF
    Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated leukocyte cell adhesion molecule (ALCAM)/CD166 in pancreatic cancer, a pivotal link to clinical outcome and vascular embolism.
    Yang Y; Sanders AJ; Ruge F; Dong X; Cui Y; Dou QP; Jia S; Hao C; Ji J; Jiang WG
    Am J Cancer Res; 2021; 11(12):5917-5932. PubMed ID: 35018233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function.
    Ikeda K; Quertermous T
    J Biol Chem; 2004 Dec; 279(53):55315-23. PubMed ID: 15496415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the cell to cell adhesion molecule, ALCAM, in breast cancer patients and the potential link with skeletal metastasis.
    Davies SR; Dent C; Watkins G; King JA; Mokbel K; Jiang WG
    Oncol Rep; 2008 Feb; 19(2):555-61. PubMed ID: 18202807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
    Jezierska A; Matysiak W; Motyl T
    Med Sci Monit; 2006 Aug; 12(8):BR263-73. PubMed ID: 16865058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.
    Burkhardt M; Mayordomo E; Winzer KJ; Fritzsche F; Gansukh T; Pahl S; Weichert W; Denkert C; Guski H; Dietel M; Kristiansen G
    J Clin Pathol; 2006 Apr; 59(4):403-9. PubMed ID: 16484444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.
    Darvishi B; Boroumandieh S; Majidzadeh-A K; Salehi M; Jafari F; Farahmand L
    Exp Mol Pathol; 2020 Aug; 115():104443. PubMed ID: 32380056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
    Tachezy M; Zander H; Gebauer F; Marx A; Kaifi JT; Izbicki JR; Bockhorn M
    J Surg Res; 2012 Sep; 177(1):e15-20. PubMed ID: 22482754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients.
    Tachezy M; Effenberger K; Zander H; Minner S; Gebauer F; Vashist YK; Sauter G; Pantel K; Izbicki JR; Bockhorn M
    Int J Cancer; 2012 Jul; 131(2):396-405. PubMed ID: 21858815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated leukocyte cell adhesion molecule is a marker for thyroid carcinoma aggressiveness and disease-free survival.
    Chaker S; Kak I; MacMillan C; Ralhan R; Walfish PG
    Thyroid; 2013 Feb; 23(2):201-8. PubMed ID: 23148625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer.
    Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Taniguchi T; Yokoi K; Osada H; Sekido Y
    J Surg Res; 2013 Jan; 179(1):24-32. PubMed ID: 22985775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer.
    King JA; Tan F; Mbeunkui F; Chambers Z; Cantrell S; Chen H; Alvarez D; Shevde LA; Ofori-Acquah SF
    Mol Cancer; 2010 Oct; 9():266. PubMed ID: 20929568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer.
    Piao D; Jiang T; Liu G; Wang B; Xu J; Zhu A
    Mol Biol Rep; 2012 Jan; 39(1):661-8. PubMed ID: 21670959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion.
    Kijima N; Hosen N; Kagawa N; Hashimoto N; Nakano A; Fujimoto Y; Kinoshita M; Sugiyama H; Yoshimine T
    Neuro Oncol; 2012 Oct; 14(10):1254-64. PubMed ID: 22166264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated leukocyte cell-adhesion molecule (ALCAM) promotes malignant phenotypes of malignant mesothelioma.
    Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Yokoi K; Osada H; Sekido Y
    J Thorac Oncol; 2012 May; 7(5):890-9. PubMed ID: 22722789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma.
    Wachowiak R; Mayer S; Kaifi J; Gebauer F; Izbicki JR; Lacher M; Bockhorn M; Tachezy M
    Anticancer Res; 2016 Aug; 36(8):3991-5. PubMed ID: 27466504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.